<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="topic" /><meta name="keywords" content="Venous thromboembolism; Thrombosis: prophylaxis" /><meta name="IX" content="Venous thromboembolism; Thrombosis: prophylaxis" /><title>Venous thromboembolism: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="208578.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="208578.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=208578.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2760.htm">2.8 Anticoagulants and protamine</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2760.htm" title="Previous: 2.8 Anticoagulants and protamine">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="2761.htm" title="Next: 2.8.1 Parenteral anticoagulants">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>British National Formulary (5)</h3></li><li><a href="11290.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Heparin</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants</p></div></li><li><a href="12330.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Heparinoids</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants</p></div></li><li><a href="201052.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Coumarins and phenindione</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.2 Oral anticoagulants</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22venous+thromboembolism%22%22thrombosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/11290.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Heparin</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.1 Parenteral anticoagulants</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2791.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.8.2 Oral anticoagulants</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2802.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.9 Antiplatelet drugs</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system</p></div></li></ul><ul><li><h3>Dietary Supplements (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c31.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Curcumin</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c35.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fish oils</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; F</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c39.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Folic acid</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; F</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22venous+thromboembolism%22%22thrombosis%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/850-a11-2-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Thromboembolic disorders</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Other Vascular Disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/850-a11-4-e.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Peripheral arterial thromboembolism</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Other Vascular Disorders &gt; Thromboembolic disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/850-a11-3-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venous thromboembolism</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Other Vascular Disorders &gt; Thromboembolic disorders</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_208578">Venous thromboembolism</h1><?highlighter on?><div id="pC" class="jN"><p>Venous thromboembolism
includes deep-vein thrombosis and pulmonary embolism, and occurs as
a result of thrombus formation in a vein.</p><div id="_208581"><div class="cAZ"><h2>Prophylaxis of venous thromboembolism</h2> <p class="cAX">All patients admitted
to hospital should undergo a risk assessment for venous thromboembolism
on admission. Patients considered to be at high risk include those
anticipated to have a substantial reduction in mobility, those with
obesity, malignant disease, history of venous thromboembolism, thrombophilic
disorder, or patients over 60 years. Patients with risk factors for
bleeding (e.g. acute stroke, thrombocytopenia, acquired or untreated
inherited bleeding disorders) should only receive pharmacological
prophylaxis when the risk of bleeding does not outweigh the risk of
venous thromboembolism. A NICE Guideline<sup class="footnote"><a title="Go to footnote" href="208578.htm#footnote208583">(1)</a></sup> provides a full list of risk factors,
and gives recommendations for prophylaxis. A venous thromboembolism
risk assessment checklist is also available from the Department of
Health (<a href="http://www.dh.gov.uk" title="external link">www.dh.gov.uk</a>).</p><p>Patients scheduled for surgery should be offered mechanical
prophylaxis (e.g. anti-embolism stockings) on admission if appropriate;
prophylaxis should continue until the patient is sufficiently mobile.
Choice of mechanical prophylaxis will depend on factors such as the
type of surgery, suitability for the patient, and their condition.</p><p>Patients undergoing general or orthopaedic surgery, who are
considered to be at high risk of venous thromboembolism (see above),
should be offered pharmacological prophylaxis. Choice of prophylaxis
will depend on the type of surgery, suitability for the patient, and
local policy. A low molecular weight heparin is suitable in all types
of general and orthopaedic surgery; unfractionated heparin is preferred
for patients in renal failure. Fondaparinux is an option for patients
undergoing hip or knee replacement surgery, hip fracture surgery,
gastro-intestinal, bariatric, or day surgery procedures. The oral
anticoagulants dabigatran etexilate and rivaroxaban are indicated
for thromboprophylaxis following hip or knee replacement surgery (see <a title="BNF:sub-section: Oral anticoagulants" href="2791.htm#_2791">section 2.8.2</a>). Pharmacological prophylaxis
in general surgery should usually continue for 5–7 days, or until
sufficient mobility has been re-established. Pharmacological prophylaxis
should be extended to 28 days after major cancer surgery in the abdomen
or pelvis. Hip or knee replacement surgery, and hip fracture surgery,
require an extended duration of pharmacological prophylaxis, depending
on the preparation used (consult product literature).</p><p>General medical patients who are considered to be at high risk
of venous thromboembolism (see above) should be offered pharmacological
prophylaxis on admission. Choice of prophylaxis will depend on the
medical condition, suitability for the patient, and local policy.
Patients should receive either a low molecular weight heparin, unfractionated
heparin (if patient in renal failure), or fondaparinux. Prophylaxis
should continue until the patient is no longer considered to be at
significant risk of venous thromboembolism. Mechanical prophylaxis
(e.g. anti-embolism stockings) can be offered to medical patients
in whom pharmacological prophylaxis is contra-indicated, and continued
until the patient is sufficiently mobile.</p></div></div></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2760.htm">Previous: 2.8 Anticoagulants and protamine</a> | <a class="top" href="208578.htm#">Top</a> | <a accesskey="]" href="2761.htm">Next: 2.8.1 Parenteral anticoagulants</a> ►</div><div class="cF"><div class="footnote" id="footnote208583"><sup>(1)</sup>NICE clinical guideline 92 (January 2010). Venous thromboembolism:
reducing the risk</div></div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>